Market research
NVCN.TO Neovasc Inc
TO CAD Healthcare
Latest close
Latest stored close unavailable
Test a moving-average rule with historical data.
Market facts
- Market cap
- 112M
- P/E ratio
- Not available
- Analyst target
- 2.15
- Dividend yield
- 0.0%
- Beta
- 2.01
Profile
Instrument facts
- Exchange
- TO
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- CA64065J3047
- Market cap
- 112M
- P/E ratio
- Not available
- Analyst target
- 2.15
- Dividend yield
- 0.0%
- Beta
- 2.01
About
About Neovasc Inc
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include Tiara for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada. As of April 11, 2023, Neovasc Inc. operates as a subsidiary of Shockwave Medical, Inc.
Research context
Neovasc Inc appears in PyInvesting’s Toronto Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Medical Devices
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the NVCN.TO discussion.
5 years, 6 months ago
Neovasc Inc is currently in a long term downtrend where the price is trading 27.4% below its 200 day moving average.
From a valuation standpoint, the stock is 99.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 9.3.
Neovasc Inc's total revenue sank by 9.2% to $514K since the same quarter in the previous year.
Its net income has increased by 64.2% to $-4M since the same quarter in the previous year.
Finally, its free cash flow fell by 12.7% to $-7M since the same quarter in the previous year.
Based on the above factors, Neovasc Inc gets an overall score of 2/5.